Advanced NMR calls off AMS merger

Article

Advanced NMR announced last week that it has canceled its proposedmerger with Advanced Mammography Systems, the breast MRI developerof which it owns a majority interest.Advanced NMR, of Wilmington, MA, had originally planned to bringAMS under its wing

Advanced NMR announced last week that it has canceled its proposedmerger with Advanced Mammography Systems, the breast MRI developerof which it owns a majority interest.

Advanced NMR, of Wilmington, MA, had originally planned to bringAMS under its wing because of capitalization issues at the subsidiary.AMS recently completed a private placement of $3 million worthof convertible debentures, however, enabling the unit to remainindependent. Proceeds from the debenture issue will be used toaccelerate the completion of product development for AdvancedMammography Systems' Aurora dedicated breast MRI scanner and tofund a global product launch of the machine.

The merger cancellation renders moot a class action shareholderlawsuit filed against Advanced NMR earlier this year seeking tostop the merger (SCAN 2/28/96). Advanced NMR will continue toown 61% of AMS.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.